Anzeige
Mehr »
Dienstag, 28.07.2026 - Börsentäglich über 12.000 News
Rohstoffstory der Spitzenklasse: Wie genau schauen Sie hin?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
167 Leser
Artikel bewerten:
(0)

Black Book Research: Black Book: Healthcare Supply Chain IT Enters a 2027 Replacement Supercycle as 71% Plan Major Upgrades

Nine in ten surveyed healthcare leaders rank supply chain among their top three non-labor financial levers, while 74% require measurable value from new platforms within 12 months

SAN ANTONIO, TX / ACCESS Newswire / July 28, 2026 / Healthcare supply chain technology is moving into a major replacement, consolidation and modernization cycle as health systems connect procurement performance directly to operating margin, working capital and continuity of care, according to Black Book Research's 2027 outlook.

Black Book's validated healthcare supply chain study found that 71% of respondents expect their organizations to replace or materially upgrade at least one major supply chain application, module or technology overlay within the next 24 months.

At the same time, 90% identify supply chain as one of their organizations' three most important non-labor levers for improving financial performance, and 74% require meaningful value from newly approved platforms or services within 12 months or less. Another 57% expect to rationalize point solutions in favor of connected platforms, overlays or managed ecosystems.

The demand is being driven by substantial operational debt. Eighty-one percent lack near-real-time visibility across critical supply domains, suppliers and sites of care; 72% report that at least half of their critical exception workflows remain primarily manual; and 77% identify substitute identification and approval as one of their three most disruptive supply chain bottlenecks.

"2027 will be the year healthcare supply chain technology has to clear the same investment hurdle as revenue-cycle optimization or labor-productivity transformation," said Doug Brown, Founder of Black Book Research. "A platform that cannot reconcile contract price to purchase order, invoice, inventory consumption and clinical substitution is not a transformation program-it is another layer of software expense. CFOs will fund the systems that release working capital, reduce contract leakage and emergency purchasing, accelerate inventory turns and produce realized savings inside the first operating year."

From requisition automation to closed-loop financial execution

The next generation of healthcare supply chain modernization will extend beyond electronic requisitioning and catalog management. Black Book expects 2027 buyers to demand a closed-loop architecture connecting:

  • Item, supplier, location and UDI master data

  • Sourcing events, negotiated contracts and GPO price tiers

  • Guided buying, approvals, purchase orders and invoice matching

  • Receiving, warehouse, point-of-use and replenishment transactions

  • Clinical utilization, substitutions, recalls and product conversions

  • Financial posting, benefits realization and contract-performance governance

That architecture will allow procurement, finance, clinical value analysis and materials management teams to measure the difference among identified savings, negotiated savings, implemented conversion and validated financial benefit.

Client-rated vendors aligned with the 2027 purchasing agenda

Black Book's previously published 2026 client-rated category leaders represent several distinct layers of the modernization stack:

Infor - Enterprise ERP, MMIS and procure-to-pay backbone. Infor CloudSuite Healthcare combines finance, procurement, materials management, inventory, distribution, workforce and interoperability capabilities in a healthcare-oriented cloud environment. The critical implementation test will be whether health systems can standardize controls without losing low-unit-of-measure distribution, clinical exceptions, multi-entity governance or local operating visibility.

Coupa - Strategic sourcing, contracting and spend optimization. Coupa's source-to-pay capabilities connect spend analysis, guided buying, sourcing, supplier management, contracting and invoicing. Black Book identifies compliant spend, sourcing throughput, touchless transactions, contract adherence, user adoption and verified savings as more important measures than module breadth alone.

Premier, Inc. - GPO, provider coalition and purchasing support. Premier combines contract access, supply chain analytics, sourcing support, consulting and clinical performance capabilities. The financial test is whether negotiated pricing becomes implemented utilization change and auditable local savings rather than remaining an unconverted contract opportunity.

BlueBin - Inventory, warehouse, point-of-use and replenishment automation. BlueBin combines a two-bin Kanban operating model with implementation services, visual management, scanning and analytics. Its value case centers on reducing excess inventory, stockouts, expirations, replenishment labor and clinician search time while sustaining standardized work after deployment.

symplr - Supplier networks, data exchange, credentialing and relationship management. The supplier-control layer is expanding from basic vendor access toward identity, credentialing, onboarding, transaction quality, policy enforcement and enterprise relationship governance. symplr was the published 2026 Black Book leader in this category.

The 2027 ROI standard

Black Book expects capital approvals to increasingly require a reconciled benefits ledger built from preimplementation baselines. Relevant measures will include:

  • Days inventory on hand and working-capital release

  • Purchase-price variance and contract-compliance rates

  • Off-contract and unauthorized spend

  • Purchase-order and invoice exception rates

  • Stockouts, expirations and avoidable waste

  • Premium freight and emergency purchasing

  • Replenishment labor and clinician search time

  • Procedure delays, substitutions and avoided disruptions

"Identified opportunity" will no longer be sufficient. Buyers will increasingly require contractual acceptance criteria, executive governance, measurable operating targets and a defined timetable for converting platform capability into financial results.

Black Book's outlook is that the strongest 2027 demand will concentrate on platforms that can integrate procurement, MMIS, ERP, supplier data, clinical utilization and point-of-use execution without requiring health systems to maintain another collection of disconnected dashboards. AI-enabled sourcing and forecasting will advance, but production adoption will depend on explainability, human decision rights, data quality and evidence that automation reduces cycle time and manual intervention.

Research Methodology

The underlying validated study included 1,335 healthcare supply chain and technology respondents representing 1,019 provider organizations, with results reported at a 95% confidence level and approximately ±2.7 percentage points.

The companion State of Healthcare Supply Chain Management Technology Q3 2026 report maps 36 coherent technology and services categories, 18 qualitative performance indicators and 144 participating organizations across enterprise platforms, procurement, clinical supply execution, distribution, logistics, intelligence, risk, automation and managed services. Only previously published Black Book client-rated category leaders are identified as award recipients in this announcement; Q3 modeled scores are excluded from external claims.

About Black Book Research

Black Book Research produces independent, crowdsourced buyer intelligence and global client-experience benchmarks across healthcare technology, services and operating models. Its healthcare supply chain research examines the intersection of procurement, technology, clinical operations, logistics, pharmacy, asset management, data integrity and financial performance. Doug Brown, founder is also the author of this year's "The Black Book of Reshoring: The Essential Guide to America's Manufacturing Boom" (Wiley, 2026) and the WSJ bestselling "The Black Book of Outsourcing" (Wiley, 2005) Download the report from https://www.blackbookmarketresearch.com or https://www.blackbookinsights.com or request through media office by email.

Media Contact:
Black Book Research
research@blackbookmarketresearch.com
1.800.863.,7590

SOURCE: Black Book Research



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/black-book-healthcare-supply-chain-it-enters-a-2027-replacement-super-1197393

© 2026 ACCESS Newswire
Achtung, Korrektur!
Die Börsen laufen heiß. Trotz geopolitischer Krisen und steigender Zinsen klettern viele Indizes weiter Richtung Allzeithoch. Doch unter der Oberfläche zeigen sich erste Risse: Der Abverkauf bei Halbleiter-, KI- und Space-Aktien macht deutlich, wie schnell sich die Stimmung drehen kann.

Besonders gefährlich ist die aktuelle Gemengelage aus schwacher Saisonalität, dünner Liquidität in den Sommermonaten und historisch hohen Bewertungen. Selbst vermeintlich sichere Blue Chips sind inzwischen teuer bewertet und damit anfällig für Korrekturen. Gleichzeitig liefern technische Indikatoren erste Warnsignale. So werden viele Rekordstände nicht mehr bestätigt.

Für Anleger steigen die Risiken spürbar. Wer jetzt nicht genauer hinschaut, läuft Gefahr, auf dem falschen Fuß erwischt zu werden.

In unserem aktuellen Spezialreport zeigen wir fünf Aktien, bei denen die Abwärtsrisiken besonders hoch sind – und wo sich Gewinnmitnahmen oder sogar Short-Strategien anbieten könnten.

Jetzt den kostenlosen Report sichern – bevor die Korrektur Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.